Table 6.

Criteria for extended VTE chemoprophylaxis postdischarge

Questions	Medical directors	Membership	Total	P- value
What are the criteria for extended chemoprophylaxis on discharge?†
Age	11 (3.4%)	9 (2.4%)	20 (2.8%)	.541
Gender	8 (2.5%)	5 (1.3%)	13 (1.8%)	.331
BMI > 40	1 (.3%)	2 (.5%)	3 (.4%)	1.000
BMI > 50	30 (9.2%)	33 (8.7%)	63 (8.9%)	.850
BMI > 60	13 (4%)	21 (5.5%)	34 (4.8%)	.179
Family or personal history of PE/DVT	53 (16.2%)	69 (18.1%)	122 (17.2%)	.039*
Immobility/paraplegia	41 (12.5%)	45 (11.8%)	86 (12.2%)	.815
Operative length	9 (2.8%)	12 (3.2%)	21 (3%)	.576
Based on risk calculator	39 (11.9%)	41 (10.8%)	80 (11.3%)	.965
Use of anticoagulants	22 (6.7%)	30 (7.9%)	52 (7.3%)	.281
Congestive heart failure	5 (1.5%)	8 (2.1%)	13 (1.8%)	.448
Length of stay	3 (.9%)	3 (.8%)	6 (.9%)	1.000
COVID	3 (.9%)	4 (1.1%)	7 (1%)	1.000
Pulmonary hypertension	5 (1.5%)	1 (.3%)	6 (.9%)	.110
Birth control pills/hormonal replacement	8 (2.5%)	9 (2.4%)	17 (2.4%)	.896
Inflammatory bowel disease	1 (.3%)	4 (1.1%)	5 (.7%)	.369
Venous stasis	15 (4.6%)	17 (4.5%)	32 (4.5%)	.832
Hypercoagulable state	48 (14.7%)	64 (16.8%)	112 (15.8%)	.044*
Other	12 (3.7%)	4 (1.1%)	16 (2.3%)	.026*

VTE = venous thromboembolism; PE = pulmonary embolism; DVT = deep vein thrombosis.

Data are expressed as n (%).

P-value is calculated using Chi-square or Fisher’s exact test when appropriate.

^*The difference is significant at the .05 level.

^†Multiple response questions.